Last Updated: May 30, 2026

INGENUS Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for INGENUS

INGENUS has forty approved drugs.

Summary for INGENUS

US Patents:	0
Tradenames:	40
Ingredients:	40
NDAs:	40

Drugs and US Patents for INGENUS

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ingenus Pharms Llc	TOPOTECAN HYDROCHLORIDE	topotecan hydrochloride	INJECTABLE;INJECTION	206962-001	Nov 30, 2016	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Ingenus Pharms Llc	MEXILETINE HYDROCHLORIDE	mexiletine hydrochloride	CAPSULE;ORAL	214352-002	Jan 25, 2021	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Ingenus Pharms Llc	IVABRADINE HYDROCHLORIDE	ivabradine hydrochloride	TABLET;ORAL	214051-001	Dec 30, 2021	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Ingenus Pharms Llc	TRIAZOLAM	triazolam	TABLET;ORAL	214219-001	Oct 20, 2020	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Ingenus Pharms Nj	MORPHINE SULFATE	morphine sulfate	TABLET;ORAL	215584-001	Feb 7, 2022		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Ingenus Pharms Llc	DOFETILIDE	dofetilide	CAPSULE;ORAL	212410-001	Dec 27, 2019		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Ingenus Pharms Llc	DICLOFENAC POTASSIUM	diclofenac potassium	TABLET;ORAL	215585-001	Oct 8, 2021	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.